Alliancebernstein L.P. Stake Increase in Tempus AI, Inc.
Alliancebernstein L.P. raised its stake in Tempus AI, Inc. (NASDAQ: TEM) by 40.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 945,133 shares of the company’s stock after buying an additional 271,591 shares during the quarter. Alliancebernstein L.P. owned 0.60% of Tempus AI worth $31,908,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Kovitz Investment Group Partners LLC acquired a new stake in shares of Tempus AI during the 3rd quarter valued at about $1,367,000. Victory Capital Management Inc. bought a new position in Tempus AI during the fourth quarter valued at approximately $216,000. China Universal Asset Management Co. Ltd. acquired a new stake in Tempus AI in the fourth quarter valued at approximately $1,091,000. Mirae Asset Global Investments Co. Ltd. bought a new stake in Tempus AI in the fourth quarter worth approximately $178,000. Finally, abrdn plc acquired a new position in shares of Tempus AI during the 4th quarter worth $2,784,000. Institutional investors and hedge funds own 24.22% of the company’s stock.
Analyst Ratings for Tempus AI
Several research firms recently issued reports on TEM. Morgan Stanley lifted their price objective on shares of Tempus AI from $50.00 to $60.00 and gave the company an “overweight” rating. Loop Capital reduced their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company. Guggenheim reissued a “buy” rating on shares of Tempus AI. Piper Sandler reduced their target price on Tempus AI from $70.00 to $55.00 and set a “neutral” rating. Finally, Needham & Company LLC increased their price target on Tempus AI from $56.00 to $70.00 and gave the company a “buy” rating. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $61.18.
Tempus AI Stock Performance
NASDAQ TEM opened at $42.58 on Monday. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $91.45. The firm has a 50-day simple moving average of $58.27 and a 200-day simple moving average of $51.45. The company has a current ratio of 2.69, a quick ratio of 2.55, and a debt-to-equity ratio of 8.17.
Insiders Activity
In related news, Director Wayne A.I. Frederick sold 3,000 shares of the firm’s stock. Director Nadja West sold 809 shares of the stock. In the last quarter, insiders sold 5,601,969 shares of company stock worth $317,330,782.
About Tempus AI: Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development, and delivery of optimal therapeutics.
